This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Oct;50(10):625-6.

doi: 10.2165/11594340-000000000-00000.

Pharmacometrics for regulatory decision making: status and perspective

Efthymios Manolis¹, Ralf Herold

Affiliations

PMID: 21895035
DOI: 10.2165/11594340-000000000-00000

Comment

Pharmacometrics for regulatory decision making: status and perspective

Efthymios Manolis et al. Clin Pharmacokinet. 2011 Oct.

. 2011 Oct;50(10):625-6.

doi: 10.2165/11594340-000000000-00000.

Authors

Efthymios Manolis¹, Ralf Herold

Affiliation

¹ European Medicines Agency (EMA), London, UK.

PMID: 21895035
DOI: 10.2165/11594340-000000000-00000

No abstract available

PubMed Disclaimer

Comment on

Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008.
Lee JY, Garnett CE, Gobburu JV, Bhattaram VA, Brar S, Earp JC, Jadhav PR, Krudys K, Lesko LJ, Li F, Liu J, Madabushi R, Marathe A, Mehrotra N, Tornoe C, Wang Y, Zhu H. Lee JY, et al. Clin Pharmacokinet. 2011 Oct;50(10):627-35. doi: 10.2165/11593210-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21895036

References

1. Br J Clin Pharmacol. 2009 Oct;68(4):493-501 - PubMed
1. Paediatr Anaesth. 2011 Mar;21(3):214-21 - PubMed
1. Clin Pharmacokinet. 2011 Oct;50(10):627-35 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer